How many investments has NXT2B made?

NXT2B has 9 tracked investments.

What stage does NXT2B invest at?

NXT2B invests at the Seed, Series A, Series B, Growth stages.

What sectors does NXT2B focus on?

NXT2B focuses on Biotech, Consumer, Healthtech, Medical Devices.

Where is NXT2B located?

NXT2B is headquartered in Uppsala, SE.

NXT2B

Venture capital

Uppsala · Seed–Growth · 4 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into NXT2B

202 people in our graph share verified history with the NXT2B team — schools, employers, funds. One of them is your warm intro.

Kike Mirallesunlockedknows Erika Kjellberg Eriksson · together at Universidad Complutense de Madrid

×6knows the team · via Universidad Autónoma de Madrid

×5knows the team · via Universidad Complutense de Madrid

✨ Fox Verdict

Investment thesis

NXT2B is a fully privately owned venture capital firm that funds investments with its own capital, enabling fast decisions without reliance on external funding. It partners with competent, ambitious entrepreneurs and focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies, while also backing technology and consumer companies with distinctive ideas. The firm targets early-phase projects of high scientific quality with reasonable commercial potential, committing to long-term relationships. NXT2B emphasizes active ownership, working alongside portfolio management teams to build market-leading companies, and draws on proven experience commercializing innovative projects.

Invests inBiotech Consumer Healthtech Medical Devices Europe Sweden

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Growth

Uppsala, SE

Instruments

Equity

Founded

2011

Tracked investments

Team · 4 people

from the firm's website & public directories

Erika Kjellberg Eriksson· CEO and Chair of the Board· Greater Uppsala Metropolitan Areain

Erika has over 20 years in the life science sector, previously serving as CFO of OxThera, VP and CFO of Q-Med, and CFO and CEO of BioPhausia. She holds a B.Sc. in Business and Economics from Uppsala University and began her career as an auditor at Ernst & Young.

e•••@nxt2b.comreveal

Angelica Loskog· Scientific adviser

Angelica is CEO of Lokon Pharma AB and a Professor of Immunotherapy at Uppsala University, working in immune, gene and cell therapy with a focus on cancer and autoimmune disease.

Bengt Ågerup· Senior Adviser

Swedish entrepreneur who founded NXT2B in 2011 and now serves as senior adviser. He previously held senior positions at Pharmacia and Biomatrix and founded Q-Med (maker of Restylane), later sold to Galderma. He has also served on the board of the Swedish Foundation for Strategic Research and chaired Stockholm Uppsala Life Science.

Per-Olof Wallström· Member of the Board

Per-Olof has 50 years of experience in the pharmaceutical and biotech industry, holding senior roles at Merck AB, Astra AB, Pharmacia AB and Bristol-Myers Squibb AB. He has served as CEO of Karo Bio AB, Melacure Therapeutics AB and Q-Med AB.

Investments · 9 tracked

founders shown can be your intro path

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AllgoHolding ABHansa Biopharma ABLokon Pharma ABLumina Adhesives ABNavinci Diagnostics ABQ-linea ABRepos Pharma ABScint-X ABVivolux AB

Frequently asked questions

How many investments has NXT2B made?: NXT2B has 9 tracked investments.
What stage does NXT2B invest at?: NXT2B invests at the Seed, Series A, Series B, Growth stages.
What sectors does NXT2B focus on?: NXT2B focuses on Biotech, Consumer, Healthtech, Medical Devices.
Where is NXT2B located?: NXT2B is headquartered in Uppsala, SE.

Similar investors

ACT Venture Capital

ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.

$1.1M – $16.2M

Amadeus Capital Partners

Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.

$50K – $12.7M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

EDB Investments

EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.